stockrowWest Pharmaceutical Services, Inc.
WST Healthcare Medical Instruments & Supplies
West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024.
- Revenue
- +8.69%
- EPS
- +56.7%
- Free cash flow
- +12.3%
- Total debt
- +0.10%
Quarter to September 2026, against a year earlier
Follow WST
Alert me
West Pharmaceutical Services, Inc. (WST) Return on equity
West Pharmaceutical Services, Inc.'s return on equity over the twelve months to 30 September 2026 was 21.2%, up 4.4 percentage points from fiscal 2025 (16.9%). Over the past ten years it has ranged from 9.65% (fiscal 2015) to 31.6% (fiscal 2021); the current reading is higher than 55% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 16.9% | (0.86) |
| FY2024 | 17.7% | (3.61) |
| FY2023 | 21.3% | (2.02) |
| FY2022 | 23.3% | (8.25) |
| FY2021 | 31.6% | 11.39 |
| FY2020 | 20.2% | 3.92 |
| FY2019 | 16.3% | 0.82 |
| FY2018 | 15.5% | 2.89 |
| FY2017 | 12.6% | (0.84) |
| FY2016 | 13.4% | 3.76 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| RMD ResMed Inc. compare | 26.4% |
| WST West Pharmaceutical Services, Inc. | 21.2% |
| COO The Cooper Companies, Inc. compare | 6.84% |
| BDX Becton, Dickinson and Company compare | 3.77% |
| SOLV Solventum Corporation compare | 3.19% |
| MDLN Medline Inc. compare | 3.18% |
| ALC Alcon compare | 2.94% |
| ALGN Align Technology, Inc. compare | 0.00% |
| BAX Baxter International Inc. compare | −10.6% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on WST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement